Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
Can Urol Assoc J. 2008 Dec;2(6):631-4.

Treatment of adult rhabdoid renal cell carcinoma with sorafenib.

Author information

  • 1Division of Urology, Department of Surgery, McMaster University, Hamilton, Ont., and the.

Abstract

Renal cell carcinoma (RCC) with rhabdoid features is an uncommon and highly aggressive malignancy. We report a case of adult clear-cell RCC with extensive rhabdoid features treated with the tyrosine kinase inhibitor sorafenib. A review of the literature summarizes important aspects of this malignancy. We discuss clinical and histological findings as well as the patient's response to sorafenib therapy.

PMID:
19066685
[PubMed]
PMCID:
PMC2593598
Free PMC Article

Images from this publication.See all images (4)Free text

Fig. 1
Fig. 2
Fig. 3
Fig. 4
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Icon for PubMed Central
    Loading ...
    Write to the Help Desk